ClinicalTrials.govpublic full text
A Phase II Trial to Evaluate the Effect of Itraconazole on Pathologic Complete Response Rates in Resectable Esophageal Cancer
esophageal adenocarcinoma, esophageal squamous cell carcinoma, gastroesophageal junction carcinoma, itraconazole, neoadjuvant, interventional, phase2
This document is indexed with metadata only — full text is not available in the archive for this record.
Open the official source ↗
Related documents
Record · ID 992516
Retrieved via
Conceptio — every document is proof-bundled with source, license, and retrieval metadata.